Clinical Trial Update: Effect of Duolac 7S Administration on Improving Symptom in Irritable Bowel Syndrome [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluated whether Duolac 7S administration improves symptoms in irritable bowel syndrome. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome

Drugs mentioned

• Duolac 7S

Snippet

Sponsor: Cell Biotech Co., Ltd. | Conditions: Irritable Bowel Syndrome | Phase 3 | Status: COMPLETED